—— 要投稿,上万维,轻松学术交流

严正声明

本站非期刊官网,非中介代理,
不向作者收取任何费用!
举报微信:13140028228 冯老师

态度公正、信息求实、投稿自助、使用免费
生物化学与生物物理学报(英文版)(Acta Biochimica et Biophysica Sinica)
月刊 -
  • 生物化学与生物物理学报(英文版)(Acta Biochimica et Biophysica Sinica)
  • SCIE外文期刊
  • 期发文量0
  • 国人占比-
  • 万方目次,知网目次
  • 投稿方式--官网投稿
  • 期刊属性

  • 中科分区:2区
    OA期刊:-
  • 综述期刊:
    TOP期刊:
  • 期均国文:0
    环比增速:%
  • 期刊信息

  • 研究方向:
  • 国际刊号:ISSN 1672-9145;EISSN1745-7270
  • 期刊语言:
    出版地区:
  • 投稿网址:https://www.sciengine.com/abbs/
  • 电子邮箱:abbs@sibs.ac.cn (官网邮箱(20220905更新))
  • 期刊官网:
  • 作者指南:
  • 出版商网址:
  • 出版地址:上海岳阳路320号31B座407室
  • 期刊简介:《生物化学与生物物理学报(英文版)》(Acta Biochimica et Biophysica Sinica)(月刊),创刊于1958年,由中国科学院主管、中国科学院分子细胞科学卓越创新中心(生物化学与细胞生物学研究所)主办。刊登生物化学、分子生物学、生物物理学领域的原创论文、通讯、综述。该刊是我国最早被SCIE收录的生物学期刊之一。

  • 万维提示

  • 1、投稿方式:在线投稿。

    2、刊内网址:http://www.abbs.org.cn/

    https://www.sciengine.com/abbs/

    3、投稿系统:https://mc.manuscriptcentral.com/abbs

    4、主办单位官网:

    http://cemcs.cas.cn/xhqk/qk/actabiochimicaetbiophysicasinica/

    (中国科学院分子细胞科学卓越创新中心(生物化学与细胞生物学研究所)

    5、出刊日期:月刊,每月出版1期。

    202295日星期一

                               

     

    《生物化学与生物物理学报(英文版)》投稿须知

    Acta Biochimica et Biophysica Sinica

    Instructions to Authors

    【官网信息】

     

    Instructions to Authors

    ABBS is a scientific journal publishing monthly original articles, short communications and review articles in Biochemistry, Molecular Biology and Biophysics. Original articles and short communications should report original work not published or considered for publication elsewhere. Reviews should provide a concise introduction to the subject matter to inform the readers of the latest developments in a certain area. ABBS also publishes brief reports, such as “new phenomenon” which reports a new finding, and “lab note” which reports an important preliminary result or a novel useful method. In addition, ABBS publishes “research highlight” which provides brief comments on a most recently published work and discusses its impact on the future research.

    Editorial Review and Acceptance

    The acceptance criteria for a manuscript are the quality and originality of the research and its significance to our readership. Except where otherwise stated, manuscripts are single-blind peer reviewed by at least two anonymous reviewers and the editor. Final acceptance or rejection rests with the Editorial Board, who reserves the right to refuse any material for publication. To verify originality, your article may be checked by the originality detection service Crossref Similarity Check.

    Submission of Manuscripts

    Manuscripts should be written in readable English and must be submitted online through our ScholarOne Manuscripts System. Once you have prepared your manuscript according to the instructions please visit the online submission website.

    Initial submission should include a cover letter (filling in the cover letter section) stating that: (i) the content has not been published or submitted for publication elsewhere, (ii) all authors are in agreement with the content of the manuscript, and (iii) a brief CV of the corresponding author. Authors must declare any financial support or relationships that may pose conflict of interest. If tables or figures have been reproduced from other sources, a letter from the copyright holder (usually the Publisher) stating authorization to reproduce the material must be attached to the covering letter.

    The final version of the accepted manuscript will be uploaded by the editorial office after pre-editing (careful check of the main text and figure quality suitable for type-setting and production). If too many language problems are to be fixed during pre-editing, authors will be contacted by the editors for the final approval.

    If you have difficulties in using the online submission system, please feel free to contact the Editorial Office at the following address:

    Editorial Office of Acta Biochimica et Biophysica Sinica

    CAS Center for Excellence in Molecular Cell Science

    Institute of Biochemistry and Cell Biology

    320 Yueyang Road, Shanghai 200031, China

    Tel: +86-21-54920956/54920955/54920954/54922862

    Fax: +86-21-54920954

    E-mail: abbs@sibs.ac.cn

    Abbreviations

    Abbreviations should be used sparingly: only where they ease the reader's task by reducing repetition of long, technical terms. Initially use the word in full, followed by the abbreviation in parentheses. Thereafter use the abbreviation only.

    Genetic nomenclature Standard genetic nomenclature should be used. For further information, including relevant websites, authors should refer to the genetic nomenclature guide in Trends in Genetics (Elsevier Science, 1998).

    Nucleotide sequence data can be submitted in electronic form to any of the three major collaborative databases: DDBJ, EMBL or GenBank. It is only necessary to submit to one database as data are exchanged between DDBJ, EMBL and GenBank on a daily basis. The suggested wording for referring to accession-number information is: 'These sequence data have been submitted to the DDBJ/EMBL/GenBank databases under accession number U12345.' Addresses are as follows:

    DNA Data Bank of Japan (DDBJ)

    EMBL Nucleotide Sequence Submissions

    GenBank

    Format of Manuscript

    For the correct format for the main document of submitted manuscripts, authors are suggested to refer to Examples on this website.

    Original Articles should be arranged in the following order: (i) title, author(s) and affiliation(s); (ii) running title; (iii) abstract and keywords; (iv) introduction; (v) materials and methods; (vi) results; (vii) discussion; (viii) acknowledgements; (ix) funding; (x) references; (xi) figure and table legends; (xii) tables; (xiii) figures. Short Communications should be arranged in the following order: (i) title, author(s) and affiliation (s); (ii) running title; (iii) abstract and keywords; (iv) introduction; (v) materials and methods; (vi) results and discussion; (vii) acknowledgements; (viii) funding; (ix) references; (x) figure and table legends; (xi) tables; (xii) figures. Lab Note and New Phenomenon should be arranged in the following order: (i) title, author(s) and affiliation(s); (ii) running title; (iii) main contents; (iv) acknowledgements; (v) funding; (vi) references; (vii) figure and table legends. The locations of figures and tables in the text should be indicated. Footnotes to the text are not allowed and any such material should be incorporated into the text as parenthetical matter.

    Title: The title should be short and informative, less than 20 words, and should not include non-standard acronyms or abbreviations.

    Authors and affiliations: (i) the full names of all authors; (ii) the addresses of the institutions at which the work was carried out together with the full postal address including post codes; (iii) the email address, telephone and facsimile numbers of the author to whom correspondence about the manuscript should be sent. The present address of any author, if different from that where the work was carried out, can be supplied as a footnote.

    Running title: A running title should be provided and should be less than 60 characters.

    Abstract: The abstract should describe clearly the aim, major findings and conclusions of the research. It must not exceed 250 words.

    Keywords: Five or fewer key words should be listed below the abstract in alphabetical order. Keywords should be taken from those recommended by the Index Medicus Medical Subject Headings (MeSH) browser list at http://www.nlm.nih.gov/mesh/meshhome.html

    Introduction: The basic principles of research, background, earlier related work and the purpose of the present studies should be described in the introduction.

    Materials and Methods: Experimental procedures should be brief but complete enough to be repeated; procedures published previously should be cited in references. Source of materials, including Company name, City, and Country should be given in bracket where they first appear.

    Results: It is recommended that results be presented in figures and tables along with a suitable description in the text.

    Discussion: The discussion should be concise (no more than three pages) and focus on the interpretation of the results.

    References: The Vancouver system of referencing should be used (examples are given below). In the text, references should be marked using [Arabic numerals] in the order in which they appear.

    In the reference list, if a reference has many authors, list only the first seven authors, followed by 'et al'. Reference to unpublished data and personal communications should not appear in the list but should be cited in the text only (e.g. Smith A, 2000, unpublished data). All citations mentioned in the text, tables or figures must be listed in the reference list.

    Names of journals should be abbreviated according to the style used in Index Medicus. Authors are responsible for the accuracy of the references.

    Neufeld EB, Remaley AT, Demosky SJ, Stonik JA, Cooney AM, Comly M, Dwyer NK, et al. Cellular localization and trafficking of the human ABCA1 transporter. J Biol Chem 2001, 276: 27584-27590.

    Hanahan D, Jessee J, Bloom FR. Techniques for transformation of E. coli. In: Glover DM, Hames BD eds. DNA Cloning: A Practical Approach. 2nd ed. England: Oxford University Press 1998, 122-123.

    Footnotes: A footnote below the key words can only include the present address(es) of any author(s) if different from that in the affiliation(s).

    Tables: Tables should be self-contained and complement, but not duplicate, information contained in the text. Tables should be consecutively numbered in the text in Arabic numerals. Legends should be concise but comprehensive: the table, legend and footnotes must be understandable without reference to the text. Vertical grid lines should not be used to separate columns. Each column in a table must have a heading, with units of measurement in parentheses; all abbreviations must be defined in footnotes.

    ……

    更多详情:

    https://www.sciengine.com/ABBS/authorCenter?scroll=section_1


欢迎点评!让信息更透明,使投稿更轻松!
  • 审稿时间:
    是否录用:
  • 发表排期:
    查重要求:
  • 有无课题:
    有无回复:
  • 我的学历:
    我的职称:
  • 审稿费用:
    版面费用:
  • 稿       费:
    稿件字数:
  • 投稿难度:
  • 该刊可发:
  • 投稿主题:
匿名: 验证码: 点击切换验证码
    评分:0

    验证码: 点击切换验证码